Post-approval studies (Phase 4)Looking for participantsNCT05191706
What this trial is testing
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
Who this might be right for
Cataract
EyePoint Pharmaceuticals, Inc. 60